VisionGate’s Cell-CT™ 3D Cellular Imaging Platform Detects the Presence of Cancer-Associated Cells (CACs) that have undergone Malignancy Associated Change (MAC)
April 16, 2018 09:23 ET
|
VisionGate, Inc.
SEATTLE, WA, April 16, 2018 (GLOBE NEWSWIRE) -- VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, today presented a breakthrough research study demonstrated its Cell-CT™...
VisionGate® Showcases Advances in Lung Cancer Early Detection and Treatment at the World Conference on Lung Cancer
October 19, 2017 13:54 ET
|
VisionGate, Inc.
SEATTLE, WA, Oct. 19, 2017 (GLOBE NEWSWIRE) -- VisionGate, Inc. reported significant findings in three recent studies at the 18th annual World Conference on Lung Cancer (WCLC) hosted by the...